Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114718) titled 'Clinical Observation on the Effect of Recombinant Human Brain Natriuretic Peptide in Improving Cardiac Function in Patients with Heart Failure' on Dec. 17, 2025.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Xuanwu Hospital, Capital Medical University
Condition:
Diagnosed as acute decompensated heart failure
Intervention:
Standard Therapy Group:NA
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-01-04
Target Sample Size: Standard Therapy Group:280;Standard Therapy + rhBNP Group:280;
Countries of Recruitment:
China
To know more, visit https:/...